Loading compound...
Small molecule investigational drug
CIPARGAMIN is a small molecule drug currently being studied in clinical trials. It is being investigated for its potential to treat malaria, specifically Plasmodium falciparum malaria.
How it worksThe provided data does not specify the exact biological mechanism of action for CIPARGAMIN.
Used for
MalariaPlasmodium falciparum malaria
Conditions
MalariaPlasmodium falciparum malaria
Class
Small moleculeSmall molecule investigational drug
How to take
CIPARGAMIN is currently in Phase 2 clinical development and is not yet approved for general use by regulatory agencies like the FDA.
Talk to your doctor
Questions to ask
- ·Is CIPARGAMIN part of any clinical trials I can join?
- ·How does CIPARGAMIN differ from current malaria treatments?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-25.
